slides · global inventory
Resolution
Beat collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 42,534
Current window 31,801-31,830
Pages 1,418
Rows per page 30
Beat
31,801-31,830 of 42,534
14
NeuroSense Therapeutics | Investor Presentation Deck | 33 slidesNeuroSense Therapeutics | Investor Presentation Deck | 33 slides · NeuroSense Therapeutics
Pitch deck Investor relations Beat · Solution1 hit
15
Shows balanced enrollment across key metrics like age, BMI, and disease severity (ALSFRS-R).NeuroSense Therapeutics | Investor Presentation Deck | 33 slides · NeuroSense Therapeutics
Pitch deck Investor relations Beat · Solution1 hit
16
The slide highlights clinical trial safety data for PrimeC.NeuroSense Therapeutics | Investor Presentation Deck | 33 slides · NeuroSense Therapeutics
Pitch deck Investor relations Beat · SolutionLoop · Before After1 hit
17
The slide highlights a 37.4% reduction in disease progression with statistical significance (p=0.03) in the per-protocol population, while noting a 29% reduction in the ITT analysis.NeuroSense Therapeutics | Investor Presentation Deck | 33 slides · NeuroSense Therapeutics
Pitch deck Investor relations Beat · SolutionLoop · Before After1 hit
18
The slide uses a list of icons to anchor the clinical impact of the ALSFRS-R scale.NeuroSense Therapeutics | Investor Presentation Deck | 33 slides · NeuroSense Therapeutics
Pitch deck Investor relations Beat · SolutionLoop · Cost Of Inaction1 hit
19
The chart visualizes the reduction in points lost, highlighting a 3.22 point difference (p=0.03).NeuroSense Therapeutics | Investor Presentation Deck | 33 slides · NeuroSense Therapeutics
Pitch deck Investor relations Beat · SolutionLoop · Cost Of Inaction1 hit
20
The slide uses a human body diagram to categorize ALS symptoms and bar charts to show the reduction in point loss (slower disease progression) for each category.NeuroSense Therapeutics | Investor Presentation Deck | 33 slides · NeuroSense Therapeutics
Pitch deck Investor relations Beat · Solution1 hit
21
The chart highlights a 17.2% attenuation in the decline of SVC score for the PrimeC group compared to placebo.NeuroSense Therapeutics | Investor Presentation Deck | 33 slides · NeuroSense Therapeutics
Pitch deck Investor relations Beat · Solution1 hit
22
The slide highlights the PARADIGM trial's research pillars, including proteomics, microRNA, exosomes, and neurofilaments, in partnership with institutions like MGH and Harvard.NeuroSense Therapeutics | Investor Presentation Deck | 33 slides · NeuroSense Therapeutics
Pitch deck Investor relations Beat · Solution1 hit
23
The slide uses a 'Case Study' to validate the company's own strategy of combination therapy.NeuroSense Therapeutics | Investor Presentation Deck | 33 slides · NeuroSense Therapeutics
Pitch deck Investor relations Beat · Solution1 hit
24
NeuroSense Therapeutics | Investor Presentation Deck | 33 slidesNeuroSense Therapeutics | Investor Presentation Deck | 33 slides · NeuroSense Therapeutics
Pitch deck Investor relations Beat · SolutionLoop · Quick Win Big Bet1 hit
29
The slide uses a chevron-based timeline to distinguish between past achievements (checkmarks) and future goals (dots).NeuroSense Therapeutics | Investor Presentation Deck | 33 slides · NeuroSense Therapeutics
Pitch deck Investor relations Beat · Impact & Next Steps1 hit
30
This is the final slide of the deck.NeuroSense Therapeutics | Investor Presentation Deck | 33 slides · NeuroSense Therapeutics
Pitch deck Investor relations Beat · Impact & Next Steps1 hit
07
Describes a corporate restructuring involving a split-off and subsequent acquisition.SiriusXM | Investor Presentation Deck | 16 slides · SiriusXM
Conference presentation Investor relations Beat · Solution (Provide relief)1 hit
08
Uses a before-after-bridge framework to illustrate corporate restructuring.SiriusXM | Investor Presentation Deck | 16 slides · SiriusXM
Conference presentation Investor relations Beat · Solution (Provide relief)Loop · Before After1 hit
09
The slide uses a 5-column grid layout to present strategic pillars paired with supporting evidence.SiriusXM | Investor Presentation Deck | 16 slides · SiriusXM
Conference presentation Investor relations Beat · Solution (Provide relief)1 hit
10
The slide uses two side-by-side bar charts to illustrate financial strategy.SiriusXM | Investor Presentation Deck | 16 slides · SiriusXM
Conference presentation Investor relations Beat · Solution (Provide relief)1 hit
11
SiriusXM | Investor Presentation Deck | 16 slidesSiriusXM | Investor Presentation Deck | 16 slides · SiriusXM
Conference presentation Investor relations Beat · Resolution1 hit
12
SiriusXM | Investor Presentation Deck | 16 slidesSiriusXM | Investor Presentation Deck | 16 slides · SiriusXM
Conference presentation Investor relations Beat · Resolution1 hit
13
Uses a structured table format to outline key deal terms.SiriusXM | Investor Presentation Deck | 16 slides · SiriusXM
Conference presentation Investor relations Beat · Resolution1 hit
14
The slide details the mathematical formula for the exchange ratio and the mechanics of the SplitCo acquisition.SiriusXM | Investor Presentation Deck | 16 slides · SiriusXM
Conference presentation Investor relations Beat · Resolution1 hit
15
The slide uses a bridge-like structure to calculate the final exchange ratio.SiriusXM | Investor Presentation Deck | 16 slides · SiriusXM
Conference presentation Investor relations Beat · Resolution1 hit
16
SiriusXM | Investor Presentation Deck | 16 slidesSiriusXM | Investor Presentation Deck | 16 slides · SiriusXM
Conference presentation Investor relations Beat · Resolution1 hit
31
Zegna | Investor Day Presentation Deck | 150 slidesZegna | Investor Day Presentation Deck | 150 slides · Zegna
Conference presentation Investor relations Beat · Action1 hit
32
The slide uses a value chain framework to show Zegna's role in the Tom Ford men's fashion production process.Zegna | Investor Day Presentation Deck | 150 slides · Zegna
Conference presentation Investor relations Beat · Action1 hit
33
The slide uses a value chain framework to show Zegna's post-deal integration of Tom Ford Fashion.Zegna | Investor Day Presentation Deck | 150 slides · Zegna
Conference presentation Investor relations Beat · Action1 hit
34
Includes details on ownership, duration, and scope of license categories.Zegna | Investor Day Presentation Deck | 150 slides · Zegna
Conference presentation Investor relations Beat · Action1 hit
35
Zegna | Investor Day Presentation Deck | 150 slidesZegna | Investor Day Presentation Deck | 150 slides · Zegna
Conference presentation Investor relations Beat · Action1 hit
36
The slide uses a 2x2 matrix style layout to differentiate market positioning.Zegna | Investor Day Presentation Deck | 150 slides · Zegna
Conference presentation Investor relations Beat · Action1 hit
37
This slide serves as a brand imagery showcase within a Capital Markets Day presentation.Zegna | Investor Day Presentation Deck | 150 slides · Zegna
Conference presentation Investor relations Beat · Action1 hit